View Financial HealthIofina 배당 및 자사주 매입배당 기준 점검 0/6Iofina 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 05Iofina plc, Annual General Meeting, Jun 09, 2026Iofina plc, Annual General Meeting, Jun 09, 2026. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom공시 • Apr 16Iofina plc Provides Production Guidance for the First Half of Fiscal Year 2026Iofina plc provided production guidance for the first half of fiscal year 2026. For the period, The Company now expects to exceed the previous H1 2026 production guidance of 325MT-355MT. Based on the current trends, the Company is now anticipating H1 2026 production to be closer to 385MT.공시 • Jan 13Iofina plc Provides Earnings Guidance for 2025 and Production Guidance for the First Half of 2026Iofina plc provided earnings guidance for 2025 and production guidance for the first half of 2026. For the 2025, the company's revenue are projected to surpass $65 million. For the first half of 2026, the company expects to produce between 325 MT-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT).공시 • Dec 14Iofina plc Announces the Proposed Appointment of Tim Hughes as a Non-Executive Director, Effective 1 January 2026Iofina plc announced the proposed appointment of Tim Hughes as a Non-Executive Director, to take effect from 1 January 2026. Tim has significant experience in general management in the specialty chemical industry as well as corporate and sustainability matters. Tim was a member of the Executive Committee of Synthomer plc for 11 years until 2023 as divisional director for the industrial specialties global business, which included the company's specialty iodine business, before then becoming President of Corporate Development, where he was responsible for investor relations, external affairs and the development of the company's sustainability strategy. Prior to Synthomer, Tim led the Urethane Technologies joint venture business for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University. Concurrent with his appointment, Tim will also be appointed as a member of Iofina's Audit and Remuneration Committees. Timothy John Hughes, age 61, is currently or has been a Director of the following companies within the past five years: Current Directorships at Catalyst Science Discovery Centre and Museum Trust Limited, Synthomer (UK) Limited and Chemical Industries Association Limited and Previous Directorships at Synthomer (UK) Limited.공시 • Oct 17Iofina plc Provides Production Guidance for the Second Half of 2025Iofina plc provided production guidance for the second half of 2025. For the period, the company expects production is on track to be within the production range of 400 MT - 440 MT.공시 • May 15Iofina plc, Annual General Meeting, Jun 09, 2025Iofina plc, Annual General Meeting, Jun 09, 2025. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom공시 • Apr 19Iofina plc Revises Production Guidance for First Half of 2025Iofina plc revised production guidance for first half of 2025. For the period, the company now expects total iodine production for first half of 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting.공시 • Jul 16Iofina plc Provides Production Guidance for the Second Half of 2024Iofina plc provided production guidance for the second half of 2024. The company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT.공시 • May 17Iofina plc, Annual General Meeting, Jun 13, 2024Iofina plc, Annual General Meeting, Jun 13, 2024. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom공시 • May 16Iofina plc Announces Resignation of William ("Bill") D. Bellamy as DirectorIofina plc announced that Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will retire as a Director of the Company at the close of the AGM and is therefore not being submitted for re-appointment in the business of the meeting.공시 • Jan 15Iofina plc Provides Market Update Regarding Its Activities During Fourth Quarter 2023 and Outlines Expectations for 2024Iofina plc provided a market update regarding its activities during Fourth Quarter 2023 and outlines expectations for 2024. With IO#9 plant operating at an improved production rate in the second half of Fourth Quarter 2023,crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT, which aligned with the Company's guidance that H2 2023 production would either be at the bottom or very marginally below the forecast range of 325-350MT. This nevertheless represents a13% increase over production of 282.0MT for H2 2022. Total crystalline iodine production in 2023 was up 8% to 559.3MT, compared to 2022 production levels of 516MT. The iodine spot price softened by circa five percent over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future. Demand for the Company's crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipated first half. Moving into 2024, Iofina Resources expects to produce 275MT - 295MT of crystalline iodine during the first half (H1 2023: 242MT), which would result in a 13% to 22% increase over H1 2023. The Company reiterates that H1 iodine plant production has historically always been lower than H2 production due to the effect of lower temperatures on production in the winter months, whereas H2 production benefits from greater output in the warmer summer period. Encouraging progress has also been made regarding construction plans for IO#10 plant, with groundwork at the site scheduled to commence this week. The Company expects IO#10 iodine production to commence in Third Quarter 2024 and will update on progress as appropriate. Negotiations continue to progress well with both current and potential new brine supply partners for IO#11, and the Company continues to explore options in its current core area and other new areas for next iodine production facilities. In terms of new products, Iofina Chemical will beadding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships. The Group is committed to operating its facilities with a safety-first approach and is proud to report that Iofina has had no lost time incidents since April 2021.공시 • Oct 20Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. the company expected second half production is trending towards the lower end of company's forecast of 325-350 MT.공시 • Sep 12Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. With the addition of IO#9 output, second half 2023 production is on track to meet the 325-350MT target.공시 • May 09Iofina plc, Annual General Meeting, Jun 14, 2023Iofina plc, Annual General Meeting, Jun 14, 2023, at 09:00 Coordinated Universal Time. Location: Canaccord Genuity, 88 Wood Street London United Kingdom Agenda: To receive and adopt the reports of the directors and the auditors and the audited financial statements of the Company for the year ended 31 December 2022; to re-appoint Malcolm Lewin as director; to re-appoint Mary Fallin Christensen as a director; to re-appoint UHY Hacker Young LLP as the Company's auditors to hold office from the conclusion of the AGM to the conclusion of the next meeting at which the accounts are laid before the Company and to authorise the directors to determine remuneration.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 IOFN.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: IOFN.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Iofina 배당 수익률 vs 시장IOFN.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (IOFN.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Chemicals)1.7%분석가 예측 (IOFN.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 IOFN.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 IOFN.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 IOFN.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: IOFN.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/12 02:44종가2026/06/10 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Iofina plc는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Alexander BrooksCanaccord GenuityStuart JoynerInvestec Bank plc (UK)
공시 • May 05Iofina plc, Annual General Meeting, Jun 09, 2026Iofina plc, Annual General Meeting, Jun 09, 2026. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
공시 • Apr 16Iofina plc Provides Production Guidance for the First Half of Fiscal Year 2026Iofina plc provided production guidance for the first half of fiscal year 2026. For the period, The Company now expects to exceed the previous H1 2026 production guidance of 325MT-355MT. Based on the current trends, the Company is now anticipating H1 2026 production to be closer to 385MT.
공시 • Jan 13Iofina plc Provides Earnings Guidance for 2025 and Production Guidance for the First Half of 2026Iofina plc provided earnings guidance for 2025 and production guidance for the first half of 2026. For the 2025, the company's revenue are projected to surpass $65 million. For the first half of 2026, the company expects to produce between 325 MT-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT).
공시 • Dec 14Iofina plc Announces the Proposed Appointment of Tim Hughes as a Non-Executive Director, Effective 1 January 2026Iofina plc announced the proposed appointment of Tim Hughes as a Non-Executive Director, to take effect from 1 January 2026. Tim has significant experience in general management in the specialty chemical industry as well as corporate and sustainability matters. Tim was a member of the Executive Committee of Synthomer plc for 11 years until 2023 as divisional director for the industrial specialties global business, which included the company's specialty iodine business, before then becoming President of Corporate Development, where he was responsible for investor relations, external affairs and the development of the company's sustainability strategy. Prior to Synthomer, Tim led the Urethane Technologies joint venture business for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University. Concurrent with his appointment, Tim will also be appointed as a member of Iofina's Audit and Remuneration Committees. Timothy John Hughes, age 61, is currently or has been a Director of the following companies within the past five years: Current Directorships at Catalyst Science Discovery Centre and Museum Trust Limited, Synthomer (UK) Limited and Chemical Industries Association Limited and Previous Directorships at Synthomer (UK) Limited.
공시 • Oct 17Iofina plc Provides Production Guidance for the Second Half of 2025Iofina plc provided production guidance for the second half of 2025. For the period, the company expects production is on track to be within the production range of 400 MT - 440 MT.
공시 • May 15Iofina plc, Annual General Meeting, Jun 09, 2025Iofina plc, Annual General Meeting, Jun 09, 2025. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
공시 • Apr 19Iofina plc Revises Production Guidance for First Half of 2025Iofina plc revised production guidance for first half of 2025. For the period, the company now expects total iodine production for first half of 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting.
공시 • Jul 16Iofina plc Provides Production Guidance for the Second Half of 2024Iofina plc provided production guidance for the second half of 2024. The company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT.
공시 • May 17Iofina plc, Annual General Meeting, Jun 13, 2024Iofina plc, Annual General Meeting, Jun 13, 2024. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
공시 • May 16Iofina plc Announces Resignation of William ("Bill") D. Bellamy as DirectorIofina plc announced that Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will retire as a Director of the Company at the close of the AGM and is therefore not being submitted for re-appointment in the business of the meeting.
공시 • Jan 15Iofina plc Provides Market Update Regarding Its Activities During Fourth Quarter 2023 and Outlines Expectations for 2024Iofina plc provided a market update regarding its activities during Fourth Quarter 2023 and outlines expectations for 2024. With IO#9 plant operating at an improved production rate in the second half of Fourth Quarter 2023,crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT, which aligned with the Company's guidance that H2 2023 production would either be at the bottom or very marginally below the forecast range of 325-350MT. This nevertheless represents a13% increase over production of 282.0MT for H2 2022. Total crystalline iodine production in 2023 was up 8% to 559.3MT, compared to 2022 production levels of 516MT. The iodine spot price softened by circa five percent over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future. Demand for the Company's crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipated first half. Moving into 2024, Iofina Resources expects to produce 275MT - 295MT of crystalline iodine during the first half (H1 2023: 242MT), which would result in a 13% to 22% increase over H1 2023. The Company reiterates that H1 iodine plant production has historically always been lower than H2 production due to the effect of lower temperatures on production in the winter months, whereas H2 production benefits from greater output in the warmer summer period. Encouraging progress has also been made regarding construction plans for IO#10 plant, with groundwork at the site scheduled to commence this week. The Company expects IO#10 iodine production to commence in Third Quarter 2024 and will update on progress as appropriate. Negotiations continue to progress well with both current and potential new brine supply partners for IO#11, and the Company continues to explore options in its current core area and other new areas for next iodine production facilities. In terms of new products, Iofina Chemical will beadding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships. The Group is committed to operating its facilities with a safety-first approach and is proud to report that Iofina has had no lost time incidents since April 2021.
공시 • Oct 20Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. the company expected second half production is trending towards the lower end of company's forecast of 325-350 MT.
공시 • Sep 12Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. With the addition of IO#9 output, second half 2023 production is on track to meet the 325-350MT target.
공시 • May 09Iofina plc, Annual General Meeting, Jun 14, 2023Iofina plc, Annual General Meeting, Jun 14, 2023, at 09:00 Coordinated Universal Time. Location: Canaccord Genuity, 88 Wood Street London United Kingdom Agenda: To receive and adopt the reports of the directors and the auditors and the audited financial statements of the Company for the year ended 31 December 2022; to re-appoint Malcolm Lewin as director; to re-appoint Mary Fallin Christensen as a director; to re-appoint UHY Hacker Young LLP as the Company's auditors to hold office from the conclusion of the AGM to the conclusion of the next meeting at which the accounts are laid before the Company and to authorise the directors to determine remuneration.